Загрузка...
Endocrine therapy combined with targeted therapy in hormone receptor-positive metastatic breast cancer
Increasing numbers of targeted drugs are used in hormone receptor (HR)-positive metastatic breast cancer (MBC) to overcome or delay resistance to endocrine therapy. This study will systemically review the progress made in endocrine therapy combined with targeted therapy in the treatment of HR-positi...
Сохранить в:
| Опубликовано в: : | Chin Med J (Engl) |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Lippincott Williams & Wilkins
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7546887/ https://ncbi.nlm.nih.gov/pubmed/32852380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CM9.0000000000000923 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|